Data / Form D filings / CAD Therapeutics, Inc.
CAD Therapeutics, Inc.: Form D filing
CAD Therapeutics, Inc., a biotechnology company in New York, NY, filed a Form D with the SEC in 2026. The latest, on October 2, 2026, reports $4 million sold of a $10 million offering to 2 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 6 ST JOHNS LN, New York, NY, 10013
- Phone
- (646) 456-7684
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2157566
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 2 | New notice | $10,000,000 | $4,000,000 | $6,000,000 | 2 | Sep 17 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| CHRISTOPHER TEAS | Executive Officer | PRESIDENT |
| SORINA BURI | Director |
Other biotechnology companies in New York that filed recently
- Hypercell Technologies Inc. $3 million · Oct 14
Every Form D from the week of Sep 28 · All recent filings in New York · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what CAD Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.